Cambiar Investors LLC Eli Lilly & CO Transaction History

Cambiar Investors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 26, 2018	SELL	$74.21 - $87.6 $185,079 - $218,474	-2,494 Closed	0 $0
Q4 2017 Jan 30, 2018	SELL	$81.94 - $87.89 $38.6 Million - $41.4 Million	-471,147 Reduced 99.47%	2,494 $211,000
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $36.5 Million - $40.5 Million	473,641	473,641 $40.5 Million

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Cambiar Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Cambiar Investors LLC with notifications on news.